MREO
Price
$2.85
Change
-$0.02 (-0.70%)
Updated
Feb 21 closing price
Capitalization
442.16M
31 days until earnings call
TRDA
Price
$13.04
Change
-$0.03 (-0.23%)
Updated
Feb 21 closing price
Capitalization
488.14M
17 days until earnings call
Ad is loading...

MREO vs TRDA

Header iconMREO vs TRDA Comparison
Open Charts MREO vs TRDABanner chart's image
Mereo BioPharma Group
Price$2.85
Change-$0.02 (-0.70%)
Volume$815.88K
Capitalization442.16M
Entrada Therapeutics
Price$13.04
Change-$0.03 (-0.23%)
Volume$96.61K
Capitalization488.14M
MREO vs TRDA Comparison Chart
Loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MREO vs. TRDA commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (MREO: $2.89 vs. TRDA: $13.09)
Brand notoriety: MREO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 114% vs. TRDA: 87%
Market capitalization -- MREO: $442.16M vs. TRDA: $488.14M
MREO [@Biotechnology] is valued at $442.16M. TRDA’s [@Biotechnology] market capitalization is $488.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than MREO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • MREO’s TA Score: 4 bullish, 4 bearish.
  • TRDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than MREO.

Price Growth

MREO (@Biotechnology) experienced а -0.34% price change this week, while TRDA (@Biotechnology) price change was +6.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

MREO is expected to report earnings on May 14, 2025.

TRDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($488M) has a higher market cap than MREO($442M). MREO YTD gains are higher at: -17.429 vs. TRDA (-24.291). TRDA has higher annual earnings (EBITDA): 61.3M vs. MREO (-43.41M). TRDA has more cash in the bank: 449M vs. MREO (80.5M). MREO has less debt than TRDA: MREO (6.68M) vs TRDA (61.3M). TRDA has higher revenues than MREO: TRDA (215M) vs MREO (1M).
MREOTRDAMREO / TRDA
Capitalization442M488M91%
EBITDA-43.41M61.3M-71%
Gain YTD-17.429-24.29172%
P/E RatioN/A9.06-
Revenue1M215M0%
Total Cash80.5M449M18%
Total Debt6.68M61.3M11%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MREOTRDA
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
MACD
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with TERN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+0.70%
TERN - MREO
39%
Loosely correlated
+1.72%
TRDA - MREO
34%
Loosely correlated
-2.60%
URGN - MREO
34%
Loosely correlated
-1.95%
INZY - MREO
34%
Loosely correlated
-3.65%
AURA - MREO
33%
Loosely correlated
-3.77%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with IVEVF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then IVEVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-2.60%
IVEVF - TRDA
48%
Loosely correlated
N/A
CRNX - TRDA
48%
Loosely correlated
+0.91%
MGTX - TRDA
47%
Loosely correlated
+1.27%
RXRX - TRDA
46%
Loosely correlated
+1.04%
STRO - TRDA
45%
Loosely correlated
+4.47%
More